Arkolith/Insider Trading/MAIA/Form 4

Smith Stan

DirectorMAIA Biotechnology, Inc. (MAIA) · full profile →Form 4 · filed May 12, 2025
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2025Buy(P)67K$1.50$100K1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 8, 2025Buy(P)67K$2.05$137K67K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-25-013963) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML